Sam Raha is recorded as CEO and Board Member at Myriad Genetics Inc (MYGN) since April 30, 2025. Myriad Genetics Inc reported in an 8-K filed February 24, 2025 that Sam Raha was appointed member of the Board, effective April 30, 2025. Myriad Genetics Inc reported in an 8-K filed February 24, 2025 that Sam Raha was appointed President and Chief Executive Officer (CEO), effective April 30, 2025. Sam Raha has spoken on 7 earnings calls and 1 other investor event across 1 company, most recently for Myriad Genetics Inc on November 4, 2026. Myriad Genetics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Myriad Genetics Inc includes R. Bryan Riggsbee (CEO), R. Bryan Riggsbee Chief (CEO), Samraat Raha (CEO, COO and Board Member) and 7 others.
“Myriad has appointed Sam Raha, the Company’s current Chief Operating Officer (COO), as President and Chief Executive Officer (CEO) and as a member of the Board, effective April 30, 2025.”
Myriad Genetics Inc Form 8-K, filed February 24, 2025
· Read the filing
“Myriad has appointed Sam Raha, the Company’s current Chief Operating Officer (COO), as President and Chief Executive Officer (CEO) and as a member of the Board, effective April 30, 2025.”
Myriad Genetics Inc Form 8-K, filed February 24, 2025
· Read the filing
Sam Raha on recent calls
“I want to start by welcoming Vishal Sikri to our earnings call. Vishal joined Myriad in 2025 as our SVP of product and was recently promoted as Executive Vice President of Commercial, where he is now overseeing sales, marketing, and product.”
“The two primary drivers, both that led to our Q2 performance as well as the guidance change, are continued softness in a prenatal testing volume and average revenue per test there, as well as pressure on reimbursement for hereditary cancer testing.”
“I want to welcome our Chief Commercial Officer, Brian Donnelly, to the call as he will provide quarterly commercial business updates going forward, and our Chief Operating Officer, Mark Varadhi, will join us for the Q&A portion of the call.”
“While I'm pleased to lead my first earnings call as President and CEO, we had a challenging first quarter with revenue of $196 million at the lower end of our first quarter target range, representing a decline of 3% year-over-year.”
“I want to take a moment to recognize the hard work that you and our Myriad team have put in over the past 4.5 years to deliberately focus in on areas of strategic importance, divesting non-strategic assets, restructuring to get our cost basis under control, and shifting to invest and prioritize for growth.”
